NLS Sponsored content

The emergence of new technologies at the forefront of new drug development, for example gene therapy, is driving a demand for tailor-made solutions and cutting-edge expertise throughout the biopharma industry. An increasing demand for needs-adapted molecular therapeutics is placing high demands on suppliers, and, not least, on suppliers of purification solutions. Customers want tailor-made chromatography […]

The wait was over! After two long years during which numerous trade fairs could only take place virtually – or even had to be canceled – due to COVID-19, Shimadzu’s trade fair calendar is now completely full again. A big highlight on that calendar was analytica 2022 in Munich, one of the largest leading trade […]

First local managing director for Shimadzu Denmark / Joachim Holm is a sales expert with experience in pharma, life science and medical products / Expertise bolstered at the office covering the Danish market. Joachim Holm is the first local managing director of the Shimadzu office in Denmark. On 1 April, he took over the reins […]

Q&As with six Shimadzu specialists from Sweden. At the end of 2019, Shimadzu opened its own subsidiary in Sweden. It distributes Shimadzu’s full range of analytical instrumentation solutions, including chromatography, mass spectrometry, TOC (sum parameters) and spectroscopy, targeting clinical, pharmaceutical, environmental and food applications in industry and academia. Sales, service and application specialists work in […]

During 2021, the impact of COVID-19 pandemic on the life science industry moved on from initial chock to acceptance and finding a way forward. Throughout the year, COVID has been ever present, but the industry has managed the situation well. Now the sector will have to deal with the after-effects, as restrictions are removed, to […]

Tony Hitchcock, Technical Director at Cobra Biologics, a Charles River Company, is joined by Karin Agerman, Chief Research and Development Officer at CombiGene, to explore the effects of the latest regulatory guidelines from both a CDMO and drug development perspective. As the scale and number of clinical studies performed using Advanced Therapy Medicinal Products (ATMP’s) […]